The New York Times
In a finding that challenges the conventional wisdom about the risks of some hormones used in menopause, a major government study has found that years after using estrogen-only therapy, certain women had a markedly reduced risk of breast cancer and heart attack.
The research, part of the landmark Women’s Health Initiative study,
is likely to surprise women and their doctors, who for years have heard
frightening news about the risks of hormone therapy. But most of those
fears are related to the use of a combination of two hormones, estrogen
and progestin, which are prescribed to relieve hot flashes and other
symptoms of menopause, and have been shown to increase a woman’s risk of
breast cancer... Read More